Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Medifocus Inc MDFZF

Healthcare Biotechnology
Medifocus Inc develops and sells minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate, medically known as Benign Prostate Hyperplasia (BHP). It owns two focused heat technology platforms, The Endo-thermotherapy Platform-from which Prolieve was developed, can be used to treat cancers in prostate, rectal, cervical and esophageal, and The... see more

Recent & Breaking News (EXPM:MDFZF)

Medifocus, Inc. Announces Option Agreement With Major Academic Medical Center to License Technology to Develop Heat Activated and Tumor Targeted Immunotherapy

Marketwired May 27, 2015

Medifocus, Inc. Closes Equity Offering

Marketwired May 12, 2015

Medifocus Announces Retraction of Prior Press Release

Marketwired May 11, 2015

Medifocus, Inc. Announces Equity Offering

Marketwired May 11, 2015

Medifocus Inc. Announces Equity Offering

Marketwired March 27, 2015

Medifocus, Inc. Announces Financial Results for the Nine Months Ending December 31, 2014

Marketwired March 24, 2015

Medifocus, Inc. Obtains Two Newly Allowed Canadian Patents on the Prevention and Safety for the Treatment for Breast Cancer

Marketwired December 15, 2014

Medifocus, Inc.'s Technology Featured in a Mediaplanet Sponsored Insert in "USA Today" on Breast Cancer

Marketwired December 5, 2014

Medifocus, Inc. Launches Advertising and Marketing Campaign to Increase Shareholder Awareness of Its Breast Cancer Technology

Marketwired November 25, 2014

Medifocus Inc.'s Form 20-F Registration Statement Becomes Effective Immediately

Marketwired November 19, 2014

Medifocus to Be Broadcast on BNN and Fox Business News on November 8th and 9th, 2014

Marketwired November 7, 2014

Medifocus, Inc. Announces Its Sponsorship at the VM Medical 20th Anniversary Breast Cancer Conference October 23rd and 24th

Marketwired October 23, 2014

Stockhouse research points to Canadian tech deals on the rise

Chris Parry September 25, 2014

Medifocus Inc. Announces Closing of Private Placement

Marketwired September 15, 2014

Medifocus (V.MFS) jumps quarterly revenue by 32%

Stockhouse Editorial September 10, 2014

Medifocus, Inc. Announces Financial Results for the Fiscal First Quarter Ending June 30, 2014

Marketwired September 10, 2014

Medifocus Announces Retraction of Prior Press Release

Marketwired September 8, 2014

SeeThruEquity Initiates Research Coverage on Medifocus Inc. With Target Price of $0.52

Marketwired September 8, 2014

SeeThruEquity coverage positively puts MediFocus (V.MFS) target price at $0.52

Stockhouse Editorial September 3, 2014

SeeThruEquity Initiates Research Coverage on Medifocus Inc. with Target Price of $0.52

Accesswire September 3, 2014